Humax IL15 Uses, Dosage, Side Effects and more
Humax IL15 is under investigation in clinical trial NCT02633020 (Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Type II Refractory Celiac Disease).
| Attribute | Details |
|---|---|
| Trade Name | Humax IL15 |
| Generic | Ordesekimab |
| Ordesekimab Other Names | Human IgG1 anti-IL-15 monoclonal antibody, Humax IL15, Humax-IL 15 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
